Chongqing Sintaho Pharma: A trusted partner globally for chemosynthetic APIs.
01 1Chongqing Sintaho Pharmaceutical Co., Ltd.
02 1Apicore US LLC
03 1Aurobindo Pharma Limited
04 1Hetero Labs Limited
05 1Huzhou Zhanwang Pharmaceutical Co. Ltd
06 1Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
07 2LAURUS LABS LIMITED
08 1MSN Laboratories Private Limited
09 1Olon S.p.A.
10 1SHILPA PHARMA LIFESCIENCES LIMITED
11 1ScinoPharm Taiwan Ltd.
12 1Sicor S.r.l.
13 1Sicor de Mexico S.A. de C.V
14 1VALARY LAB PRIVATE LIMITED
15 1Wuhan Biocause Pharmaceutical Development Co., Ltd
01 3AZACITIDINE
02 13Azacitidine
01 4China
02 7India
03 2Italy
04 1Mexico
05 1Taiwan
06 1Blank
Chongqing Sintaho Pharma: A trusted partner globally for chemosynthetic APIs.
NDC Package Code : 84172-112
Start Marketing Date : 2024-07-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, FOR SOLUTION (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 14096-121
Start Marketing Date : 2006-08-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59651-872
Start Marketing Date : 2024-01-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51916-350
Start Marketing Date : 2012-03-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100g/100g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 42385-719
Start Marketing Date : 2013-02-07
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 42385-312
Start Marketing Date : 2021-05-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 54893-0029
Start Marketing Date : 2014-04-05
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17337-0554
Start Marketing Date : 2024-09-27
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53183-4011
Start Marketing Date : 2010-09-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 63592-1800
Start Marketing Date : 2019-06-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
A Vidaza manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Vidaza, including repackagers and relabelers. The FDA regulates Vidaza manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Vidaza API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Vidaza manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Vidaza supplier is an individual or a company that provides Vidaza active pharmaceutical ingredient (API) or Vidaza finished formulations upon request. The Vidaza suppliers may include Vidaza API manufacturers, exporters, distributors and traders.
click here to find a list of Vidaza suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Vidaza as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Vidaza API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Vidaza as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Vidaza and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Vidaza NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Vidaza suppliers with NDC on PharmaCompass.
We have 14 companies offering Vidaza
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
